Drugs with improved hydrophobicity for incorporation in medical devices
Details for Australian Patent Application No. 2006214100 (hide)
International Classifications
Event Publications
20 September 2007 PCT application entered the National Phase
PCT publication WO2006/089207 Priority application(s): WO2006/089207
31 January 2008 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 03 Jan 2008
31 May 2012 Application Accepted
Published as AU-B-2006214100
5 July 2012 Alteration of Name
The name of the applicant has been altered to Abraxis BioScience, LLC
27 September 2012 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2006214105-Cyr61 as a biomarker for diagnosis and prognosis of cancers of epithelial origin
2006214097-Radio link protocols for multi-link communication systems
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser